Pfizer’s eczema drug clears skin in mid-stage trial
Source ↗
👁 0
💬 0
Detailed results are competitive with Dupixent and Ebglyss, but the drug lacks differentiation amid an increasingly competitive landscape, one analyst argued.
Comments (0)